Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer’s pathophysiology

Although abnormal accumulation of amyloid in the brain is an early biomarker of Alzheimer’s disease (AD), wide variation in cognitive trajectories during life can be seen in the setting of brain amyloidosis, ranging from maintenance of normal function to progression to dementia. It is widely presume...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Acta Neuropathol Commun
Autores principales: Ramanan, Vijay K., Lesnick, Timothy G., Przybelski, Scott A., Heckman, Michael G., Knopman, David S., Graff-Radford, Jonathan, Lowe, Val J., Machulda, Mary M., Mielke, Michelle M., Jack, Clifford R., Petersen, Ronald C., Ross, Owen A., Vemuri, Prashanthi
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7986461/
https://ncbi.nlm.nih.gov/pubmed/33757599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-021-01154-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares